Business context and reporting period
This is Motion Acquisition Corp.’s Form 10-Q for the quarter ended March 31, 2021, not an operating-company quarterly report from DocGo. Motion was a blank-check company with no operating revenue. It had agreed on March 8, 2021 to combine with Ambulnz, Inc., doing business as DocGo; closing remained subject to stockholder and regulatory approvals and other conditions.
Financial results and liquidity
- Revenue and operations: No operating revenue. General and administrative expense was $382,816, producing an operating loss of the same amount.
- Profit: Net income was $1,989,868, mainly reflecting a $2,355,670 noncash gain from the decrease in the fair value of warrant liabilities; trust interest income was $17,014. Class B basic and diluted earnings per share were $0.69; Class A earnings per share rounded to $0.00.
- Cash flow: Operating activities used $413,578; investing activities provided $33,742, including interest released from the trust. Cash decreased by $379,836 to $498,817.
- Assets and liquidity: Total assets were $115.7 million, including $115.0 million in the trust account. Management reported approximately $539,000 of working capital and believed available resources and borrowing capacity would meet needs through the earlier of a business combination or one year from filing.
- Liabilities: Total liabilities were $10.9 million, including $6.685 million of warrant liabilities and $4.025 million of deferred underwriting commissions payable if a business combination closes. No working capital loans were outstanding. The filing reports no long-term liabilities other than these items.
- Margins and debt: Operating or net margins are not meaningful because the company had no operating revenue. No conventional borrowings were outstanding at quarter-end.
Material changes versus the prior comparable period
The filing presents no prior-year quarterly income statement or cash-flow comparison, so year-over-year changes cannot be determined from this text. From December 31, 2020 to March 31, 2021, cash fell from $878,653 to $498,817, trust investments declined from $115,020,078 to $115,003,350, and warrant liabilities declined from $9,040,670 to $6,685,000. The warrant revaluation gain drove reported quarterly net income.
Outlook, risks and unusual items
- The merger consideration contemplated 83.6 million shares for DocGo stockholders, with up to 5.0 million additional earn-out shares tied to stock-price conditions. A concurrent PIPE investment was expected to raise $125 million; proceeds from the PIPE and remaining trust funds were to be retained by DocGo upon closing.
- Motion had until October 19, 2022 to complete a business combination, subject to any approved extension. Failure to close would require redemption of public shares from the trust, while warrants could expire worthless.
- Management reported disclosure controls were ineffective at March 31, 2021 because of a material weakness in internal control over financial reporting. It described remediation efforts focused on reviewing complex securities accounting, consulting resources, and potentially adding experienced staff.
- Warrants are recorded as liabilities and remeasured at fair value each reporting period, so valuation changes can materially affect earnings without corresponding operating cash flow. The filing also notes that actual results may differ from estimates.
Important facts for investors to verify
- Confirm the reporting entity: the filing is for Motion Acquisition Corp., and its figures do not represent DocGo’s standalone operating results.
- Check the merger’s eventual approvals, closing status, final financing, redemption levels, and consideration terms.
- Review DocGo’s separate financial disclosures for operating revenue, profitability, cash flow, debt, and liquidity; this filing does not provide those metrics.
- Assess the warrant-liability accounting and the effect of subsequent fair-value changes on reported earnings.
- Review the material weakness, remediation progress, and any later disclosures on control effectiveness.